123 related articles for article (PubMed ID: 33538799)
1. AKT: a key to RT?
Brown JR
Blood; 2021 Feb; 137(5):582-584. PubMed ID: 33538799
[TBL] [Abstract][Full Text] [Related]
2. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
[TBL] [Abstract][Full Text] [Related]
3. Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation.
De Falco F; Sabatini R; Falzetti F; Di Ianni M; Sportoletti P; Baldoni S; Del Papa B; Screpanti I; Marconi P; Rosati E
Leukemia; 2015 Apr; 29(4):994-8. PubMed ID: 25425197
[No Abstract] [Full Text] [Related]
4. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
[TBL] [Abstract][Full Text] [Related]
5. Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
de Frias M; Iglesias-Serret D; Cosialls AM; Coll-Mulet L; Santidrián AF; González-Gironès DM; de la Banda E; Pons G; Gil J
Haematologica; 2009 Dec; 94(12):1698-707. PubMed ID: 19815839
[TBL] [Abstract][Full Text] [Related]
6. Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition.
Zhuang J; Hawkins SF; Glenn MA; Lin K; Johnson GG; Carter A; Cawley JC; Pettitt AR
Haematologica; 2010 Jan; 95(1):110-8. PubMed ID: 19713228
[TBL] [Abstract][Full Text] [Related]
7. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
Longo PG; Laurenti L; Gobessi S; Sica S; Leone G; Efremov DG
Blood; 2008 Jan; 111(2):846-55. PubMed ID: 17928528
[TBL] [Abstract][Full Text] [Related]
8. DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia.
Hu Y; Su H; Liu C; Wang Z; Huang L; Wang Q; Liu S; Chen S; Zhou J; Li P; Chen Z; Liu H; Qing G
Oncogene; 2017 Feb; 36(8):1038-1047. PubMed ID: 27593934
[TBL] [Abstract][Full Text] [Related]
9. Notch1 is an effector of Akt and hypoxia in melanoma development.
Bedogni B; Warneke JA; Nickoloff BJ; Giaccia AJ; Powell MB
J Clin Invest; 2008 Nov; 118(11):3660-70. PubMed ID: 18924608
[TBL] [Abstract][Full Text] [Related]
10. The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies.
Daneshmanesh AH; Hojjat-Farsangi M; Moshfegh A; Khan AS; Mikaelsson E; Österborg A; Mellstedt H
Br J Haematol; 2015 May; 169(3):455-8. PubMed ID: 25407287
[No Abstract] [Full Text] [Related]
11. The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.
Gordiienko I; Shlapatska L; Kholodniuk V; Sklyarenko L; Gluzman DF; Clark EA; Sidorenko SP
PLoS One; 2017; 12(10):e0185940. PubMed ID: 28982149
[TBL] [Abstract][Full Text] [Related]
12. Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.
Hofbauer SW; Piñón JD; Brachtl G; Haginger L; Wang W; Jöhrer K; Tinhofer I; Hartmann TN; Greil R
Cancer Res; 2010 Sep; 70(18):7336-44. PubMed ID: 20823161
[TBL] [Abstract][Full Text] [Related]
13. AKT-pathway inhibition in chronic lymphocytic leukemia reveals response relationships defined by TCL1.
Schrader A; Popal W; Lilienthal N; Crispatzu G; Mayer P; Jones D; Hallek M; Herling M
Curr Cancer Drug Targets; 2014; 14(8):700-12. PubMed ID: 25348018
[TBL] [Abstract][Full Text] [Related]
14. Common nonmutational
Fabbri G; Holmes AB; Viganotti M; Scuoppo C; Belver L; Herranz D; Yan XJ; Kieso Y; Rossi D; Gaidano G; Chiorazzi N; Ferrando AA; Dalla-Favera R
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2911-E2919. PubMed ID: 28314854
[TBL] [Abstract][Full Text] [Related]
15. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.
Palomero T; Sulis ML; Cortina M; Real PJ; Barnes K; Ciofani M; Caparros E; Buteau J; Brown K; Perkins SL; Bhagat G; Agarwal AM; Basso G; Castillo M; Nagase S; Cordon-Cardo C; Parsons R; Zúñiga-Pflücker JC; Dominguez M; Ferrando AA
Nat Med; 2007 Oct; 13(10):1203-10. PubMed ID: 17873882
[TBL] [Abstract][Full Text] [Related]
16. The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia.
Palomero T; Dominguez M; Ferrando AA
Cell Cycle; 2008 Apr; 7(8):965-70. PubMed ID: 18414037
[TBL] [Abstract][Full Text] [Related]
17. Effect of the Notch1-mediated PI3K-Akt-mTOR pathway in human osteosarcoma.
Zhang K; Wu S; Wu H; Liu L; Zhou J
Aging (Albany NY); 2021 Sep; 13(17):21090-21101. PubMed ID: 34495871
[TBL] [Abstract][Full Text] [Related]
18. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C{beta}.
Barragán M; de Frias M; Iglesias-Serret D; Campàs C; Castaño E; Santidrián AF; Coll-Mulet L; Cosialls AM; Domingo A; Pons G; Gil J
J Leukoc Biol; 2006 Dec; 80(6):1473-9. PubMed ID: 16940331
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1.
Liu ZJ; Xiao M; Balint K; Soma A; Pinnix CC; Capobianco AJ; Velazquez OC; Herlyn M
FASEB J; 2006 May; 20(7):1009-11. PubMed ID: 16571776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
